Wyden Asks CMS How It Will Enforce IRA Inflationary Rebate Provision

By Gabrielle Wanneh / February 2, 2023 at 4:42 PM
Senate Finance Committee Chair Ron Wyden (D-OR) is pressing CMS on how it will enforce the new drug pricing law’s requirement that drug makers pay rebates when they raise prices faster than the rate of inflation, saying he strongly hopes companies violating the requirement will be “penalized promptly.” In a letter to the agency Wednesday (Feb. 1) , Wyden asks for detailed information on how the inflation rebates will be handled in the Medicare Part B and D programs. He...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.